Cargando…
Erianin: A phytoestrogen with therapeutic potential
Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440559/ https://www.ncbi.nlm.nih.gov/pubmed/37608888 http://dx.doi.org/10.3389/fphar.2023.1197056 |
_version_ | 1785093182396039168 |
---|---|
author | Li, Gangmin Zhang, Huiqiong Lai, Hui Liang, Gang Huang, Jiang Zhao, Fulan Xie, Xiaofang Peng, Cheng |
author_facet | Li, Gangmin Zhang, Huiqiong Lai, Hui Liang, Gang Huang, Jiang Zhao, Fulan Xie, Xiaofang Peng, Cheng |
author_sort | Li, Gangmin |
collection | PubMed |
description | Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the anti-tumor effect of erianin, the underlying molecular mechanism has been partly clarified. In fact, the numerous pharmacological actions of erianin are complex and interrelated, mainly including ERK1/2, PI3K/Akt, JAK2/STAT3, HIF-1α/PD-L1, PPT1/mTOR, JNK/c-Jun, and p38 MAPK signal pathway. However, on account of the poor water solubility and the low bioavailability of erianin, greatly affected and limited its further development and application. And it is worthwhile and meaningful to explore more extensive pharmacological effects and mechanisms, clarify pharmacokinetics, and synthesize the derivatives of erianin. Conclusively, in this paper, the pharmacological effects of erianin and its mechanism, pharmacokinetics, and derivatives studies were reviewed, in order to provide a reference for the development and application of erianin. |
format | Online Article Text |
id | pubmed-10440559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104405592023-08-22 Erianin: A phytoestrogen with therapeutic potential Li, Gangmin Zhang, Huiqiong Lai, Hui Liang, Gang Huang, Jiang Zhao, Fulan Xie, Xiaofang Peng, Cheng Front Pharmacol Pharmacology Erianin, a phytoestrogen with therapeutic potential, is one of the major active components of Dendrobll caulis. Erianin has a variety of pharmacological effects, such as anti-tumor, anti-inflammatory, anti-diabetic retinopathy, anti-psoriasis, and antibacterial effects. Especially, in regard to the anti-tumor effect of erianin, the underlying molecular mechanism has been partly clarified. In fact, the numerous pharmacological actions of erianin are complex and interrelated, mainly including ERK1/2, PI3K/Akt, JAK2/STAT3, HIF-1α/PD-L1, PPT1/mTOR, JNK/c-Jun, and p38 MAPK signal pathway. However, on account of the poor water solubility and the low bioavailability of erianin, greatly affected and limited its further development and application. And it is worthwhile and meaningful to explore more extensive pharmacological effects and mechanisms, clarify pharmacokinetics, and synthesize the derivatives of erianin. Conclusively, in this paper, the pharmacological effects of erianin and its mechanism, pharmacokinetics, and derivatives studies were reviewed, in order to provide a reference for the development and application of erianin. Frontiers Media S.A. 2023-08-07 /pmc/articles/PMC10440559/ /pubmed/37608888 http://dx.doi.org/10.3389/fphar.2023.1197056 Text en Copyright © 2023 Li, Zhang, Lai, Liang, Huang, Zhao, Xie and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Gangmin Zhang, Huiqiong Lai, Hui Liang, Gang Huang, Jiang Zhao, Fulan Xie, Xiaofang Peng, Cheng Erianin: A phytoestrogen with therapeutic potential |
title | Erianin: A phytoestrogen with therapeutic potential |
title_full | Erianin: A phytoestrogen with therapeutic potential |
title_fullStr | Erianin: A phytoestrogen with therapeutic potential |
title_full_unstemmed | Erianin: A phytoestrogen with therapeutic potential |
title_short | Erianin: A phytoestrogen with therapeutic potential |
title_sort | erianin: a phytoestrogen with therapeutic potential |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440559/ https://www.ncbi.nlm.nih.gov/pubmed/37608888 http://dx.doi.org/10.3389/fphar.2023.1197056 |
work_keys_str_mv | AT ligangmin erianinaphytoestrogenwiththerapeuticpotential AT zhanghuiqiong erianinaphytoestrogenwiththerapeuticpotential AT laihui erianinaphytoestrogenwiththerapeuticpotential AT lianggang erianinaphytoestrogenwiththerapeuticpotential AT huangjiang erianinaphytoestrogenwiththerapeuticpotential AT zhaofulan erianinaphytoestrogenwiththerapeuticpotential AT xiexiaofang erianinaphytoestrogenwiththerapeuticpotential AT pengcheng erianinaphytoestrogenwiththerapeuticpotential |